Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ijd.12844 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lichen Planus Pigmentosus and Vitiligo in a 61-Year-Old Filipino Man: Case Report.
JMIR Dermatol
November 2024
Department of Dermatology, De La Salle Medical and Health Sciences Institute, Dasmariñas, Cavite, Philippines.
Article Synopsis
- - Pigmentary disorders like Lichen planus pigmentosus (LPP) and vitiligo can lead to significant cosmetic concerns and psychosocial stress for patients.
- - A 61-year-old man with LPP developed vitiligo and was successfully treated with low-dose isotretinoin and topical tacrolimus ointment.
- - The coexistence of LPP and vitiligo might be explained by an autoimmune process affecting skin pigmentation called melanocytorrhagy.
Quality of life in patients with acquired dermal macular hyperpigmentation: a systematic review.
Clin Exp Dermatol
November 2024
Chroma Dermatology, University of Melbourne, Carlton, VIC, Australia.
Article Synopsis
- * A review of existing literature found a lack of systematic studies on how these conditions impact patients' quality of life (QOL), with only seven studies meeting criteria to highlight impairment in QOL due to ADMH.
- * Overall, the studies suggest that ADMH significantly affects QOL, potentially more so than melasma and similar to or less than vitiligo, emphasizing the need for clinicians to consider the psychosocial aspects when managing patients with these conditions.
Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
Support Care Cancer
May 2024
Department of Dermatology, Stanford University, 450 Broadway St Pav B 4th Fl, Redwood City Palo Alto, CA, 94063, USA.
Introduction: Cutaneous adverse reactions to epidermal growth factor receptor inhibitors (EGFRi) are some of the most common side effects that patients experience. However, cutaneous adverse reactions that cause dyspigmentation in patients have been rarely reported. Erythema dyschromicum perstans (EDP) is a rare pigmentary condition that causes ashy-grey hyperpigmented macules and patches, with a few cases reported from EGFRi in the literature.
View Article and Find Full Text PDFMost Publications Regarding Platelet-Rich Plasma Use in the Knee Are From Asia, Investigate Injection for Osteoarthritis, and Show Outcome Improvement: A Scoping Review.
Arthroscopy
March 2024
Department of Orthopedic Surgery and Physical Medicine, Medical University of South Carolina, Charleston, South Carolina, U.S.A.
Purpose: To evaluate and synthesize the available literature related to platelet-rich plasma (PRP) treatment of knee pathologies and to provide recommendations to inform future research in the field.
Methods: PubMed, CINAHL, and Scopus databases were queried on October 6, 2023. All identified citations were collated and uploaded into Covidence for screening and data extraction.
Ashy Dermatosis in a Two-year-old Child: A Case Report and Mini-review.
Acta Dermatovenerol Croat
August 2023
Eri Hotta, MD, Department of Dermatology, 101 Shimokaiinnji, Shimouchida, Nagaokakyo, Kyoto, Japan;
Article Synopsis
- Ashy dermatosis, also known as erythema dyschromicum perstans, is marked by grey patches appearing on the skin, and its exact cause is still unknown.
- A case study of a two-year-old child suggests that the condition may have developed due to an infection, with the skin improving naturally over two years without treatment.
- This case is notably the second instance of ashy dermatosis reported in children under three years old, highlighting the need for further research to identify why some cases resolve on their own while others do not.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!